- A New Frontier for Convergence in Gastroenterology and Hepatology
Nov. 30(Sat) 09:00-10:30 |
Which treatment in locally advanced cancers | Diamond Hall (3F) |
Chair(s) | Jin Tae Jung (Korea), Young-Woo Kim (Korea) | |
09:00-09:22 | Locally advanced Esophageal Cancer; Pro CCRT versus Pro Surgery | Young Sin Cho (Korea) |
09:22-09:44 | Locally advanced Esophageal Cancer; Pro CCRT versus Pro Surgery | Jin-Jo Kim (Korea) |
09:44-10:06 | Locally advanced Gastric cancer; neadjuvant versus adjuvant therapy | Hee Seok Moon (Korea) |
10:06-10:28 | Locally advanced Gastric cancer; neadjuvant versus adjuvant therapy | Beom Su Kim (Korea) |
Nov. 30(Sat) 14:00-15:30 |
Controversial issues for management of advanced rectal rectal cancer | Diamond Hall (3F) |
Chair(s) | Jonghoon Lee (Korea), Jun Won Um (Korea) | |
14:00-14:22 | Preoperative stenting for left-sided obstructive disease: Should it be reserved for high risk group alone? | Jae Jun Park (Korea) |
14:22-14:44 | Optimal use of rectal radiation therapy for potentially resectable metastatic disease | Ji Ho Nam (Korea) |
14:44-15:06 | Timing of curative surgery for metastatic disease: when should we consult to surgeon? | Jin Yong Shin (Korea) |
15:06-15:28 | Recent advance of preoperative/postoperative systemic therapy | Suk-young Lee (Korea) |